291 related articles for article (PubMed ID: 23455589)
1. Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder.
Oral E; Ozcan H; Kirkan TS; Askin S; Gulec M; Aydin N
Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):685-93. PubMed ID: 23455589
[TBL] [Abstract][Full Text] [Related]
2. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
[TBL] [Abstract][Full Text] [Related]
3. Estrogen, progesterone, cortisol, brain-derived neurotrophic factor, and vascular endothelial growth factor during the luteal phase of the menstrual cycle in women with premenstrual dysphoric disorder.
Ko CH; Wong TH; Suen JL; Lin PC; Long CY; Yen JY
J Psychiatr Res; 2024 Jan; 169():307-317. PubMed ID: 38070471
[TBL] [Abstract][Full Text] [Related]
4. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
Reed SC; Levin FR; Evans SM
Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
[TBL] [Abstract][Full Text] [Related]
5. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
Lin IM; Tsai YC; Peper E; Yen CF
J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
[TBL] [Abstract][Full Text] [Related]
6. Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.
Yen JY; Lin PC; Huang MF; Chou WP; Long CY; Ko CH
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033286
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
Gurguis GN; Yonkers KA; Phan SP; Blakeley JE; Williams A; Rush AJ
Biol Psychiatry; 1998 Oct; 44(7):600-9. PubMed ID: 9787884
[TBL] [Abstract][Full Text] [Related]
8. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
Beddig T; Reinhard I; Kuehner C
Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
[TBL] [Abstract][Full Text] [Related]
9. Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder.
Lin PC; Ko CH; Lin YJ; Yen JY
Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34201084
[TBL] [Abstract][Full Text] [Related]
10. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
[TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial.
Fanaei H; Khayat S; Kasaeian A; Javadimehr M
Neuropeptides; 2016 Apr; 56():25-31. PubMed ID: 26608718
[TBL] [Abstract][Full Text] [Related]
12. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
[No Abstract] [Full Text] [Related]
13. Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder.
Comasco E; Hahn A; Ganger S; Gingnell M; Bannbers E; Oreland L; Wikström J; Epperson CN; Lanzenberger R; Sundström-Poromaa I
Hum Brain Mapp; 2014 Sep; 35(9):4450-8. PubMed ID: 24615932
[TBL] [Abstract][Full Text] [Related]
14. Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder.
Shechter A; Lespérance P; Ng Ying Kin NM; Boivin DB
PLoS One; 2012; 7(12):e51929. PubMed ID: 23284821
[TBL] [Abstract][Full Text] [Related]
15. Brain activation during emotion regulation in women with premenstrual dysphoric disorder.
Petersen N; Ghahremani DG; Rapkin AJ; Berman SM; Liang L; London ED
Psychol Med; 2018 Aug; 48(11):1795-1802. PubMed ID: 29145910
[TBL] [Abstract][Full Text] [Related]
16. Attention, response inhibition, impulsivity, and decision-making within luteal phase in women with premenstrual dysphoric disorder.
Yen JY; Lin PC; Hsu CJ; Lin C; Chen IJ; Ko CH
Arch Womens Ment Health; 2023 Jun; 26(3):321-330. PubMed ID: 37010619
[TBL] [Abstract][Full Text] [Related]
17. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
[TBL] [Abstract][Full Text] [Related]
18. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
[TBL] [Abstract][Full Text] [Related]
19. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
[TBL] [Abstract][Full Text] [Related]
20. Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls.
Rubinow DR; Smith MJ; Schenkel LA; Schmidt PJ; Dancer K
J Affect Disord; 2007 Dec; 104(1-3):37-44. PubMed ID: 17367867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
